ICD-10 Logo
ICDxICD-10 Medical Coding
ICD-10 Logo
ICDxICD-10 Medical Coding
ICD 10 CodesDiagnoses
ICD 10 CodesDiagnoses
ICD-10 Logo
ICDxICD-10 Medical Coding

Comprehensive ICD-10-CM code reference with AI-powered search capabilities.

© 2025 ICD Code Compass. All rights reserved.

Browse

  • All Chapters
  • All Categories
  • Diagnoses

Tools

  • AI Code Search
ICD-10-CM codes are maintained by the CDC and CMS. This tool is for reference purposes only.
v1.0.0
ICD-10 Guide
ICD-10 CodesR97.20

R97.20

Elevated prostate specific antigen [PSA]

BILLABLE STATUSYes
IMPLEMENTATION DATEOctober 1, 2015
LAST UPDATED09/11/2025

Code Description

ICD-10 R97.20 is a billable code used to indicate a diagnosis of elevated prostate specific antigen [psa].

Key Diagnostic Point:

Elevated prostate specific antigen (PSA) is a laboratory finding indicating higher than normal levels of PSA in the blood, which is a protein produced by both normal and malignant cells of the prostate gland. Elevated PSA levels can be indicative of various prostate conditions, including benign prostatic hyperplasia (BPH), prostatitis, and prostate cancer. The normal range for PSA levels varies, but generally, levels above 4 ng/mL are considered elevated. However, age, race, and family history can influence these thresholds. Elevated PSA is not a definitive diagnosis but rather a signal for further investigation, which may include digital rectal examination (DRE), imaging studies, or prostate biopsy. Clinicians must interpret PSA results in the context of the patient's overall clinical picture, including symptoms such as urinary difficulties, pelvic pain, or changes in urinary habits. The management of elevated PSA levels often involves monitoring and may lead to referrals to urology for further evaluation.

Code Complexity Analysis

Complexity Rating: Medium

Medium Complexity

Complexity Factors

  • Variability in normal PSA levels based on age and race
  • Need for correlation with clinical symptoms and findings
  • Potential for multiple underlying conditions causing elevation
  • Differentiation between benign and malignant causes

Audit Risk Factors

  • Inadequate documentation of clinical rationale for PSA testing
  • Failure to document follow-up actions taken based on elevated PSA
  • Misinterpretation of PSA levels without clinical correlation
  • Inconsistent coding of related conditions (e.g., BPH, prostatitis)

Specialty Focus

Medical Specialties

Internal Medicine

Documentation Requirements

Documentation should include patient history, clinical findings, and rationale for PSA testing.

Common Clinical Scenarios

Routine screening in asymptomatic patients, evaluation of urinary symptoms.

Billing Considerations

Consideration of patient age and risk factors when interpreting PSA levels.

Emergency Medicine

Documentation Requirements

Acute care documentation should detail presenting symptoms and any immediate interventions.

Common Clinical Scenarios

Patients presenting with acute urinary retention or severe pelvic pain.

Billing Considerations

Rapid assessment of PSA levels in the context of acute presentations.

Coding Guidelines

Inclusion Criteria

Use R97.20 When
  • Follow official ICD
  • CM guidelines for coding abnormal findings, ensuring that the elevated PSA is documented as a symptom or sign rather than a definitive diagnosis

Exclusion Criteria

Do NOT use R97.20 When
No specific exclusions found.

Related CPT Codes

84153CPT Code

Prostate specific antigen (PSA), total

Clinical Scenario

Used when PSA testing is performed as part of routine screening or evaluation.

Documentation Requirements

Document the reason for the PSA test and any relevant clinical findings.

Specialty Considerations

Urologists may order PSA tests more frequently for monitoring.

ICD-10 Impact

Diagnostic & Documentation Impact

Enhanced Specificity

ICD-10 Improvements

The transition to ICD-10 has allowed for more specific coding of elevated PSA levels, improving the ability to track and analyze prostate health issues.

ICD-9 vs ICD-10

The transition to ICD-10 has allowed for more specific coding of elevated PSA levels, improving the ability to track and analyze prostate health issues.

Reimbursement & Billing Impact

The transition to ICD-10 has allowed for more specific coding of elevated PSA levels, improving the ability to track and analyze prostate health issues.

Resources

Clinical References

  • •
    American Urological Association Guidelines

Coding & Billing References

  • •
    American Urological Association Guidelines

Frequently Asked Questions

What does an elevated PSA level indicate?

An elevated PSA level may indicate prostate conditions such as benign prostatic hyperplasia, prostatitis, or prostate cancer, but further evaluation is necessary to determine the cause.